Your browser doesn't support javascript.
SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools.
Cooper, Dan M; Zulu, Michael Z; Jankeel, Allen; Ibraim, Izabela Coimbra; Ardo, Jessica; Kasper, Kirsten; Stephens, Diana; Meyer, Andria; Stehli, Annamarie; Condon, Curt; Londoño, Mary E; Schreiber, Casey M; Lopez, Nanette V; Camplain, Ricky L; Weiss, Michael; Golden, Charles; Radom-Aizik, Shlomit; Boden-Albala, Bernadette; Chau, Clayton; Messaoudi, Ilhem; Ulloa, Erlinda R.
  • Cooper DM; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, USA.
  • Zulu MZ; Department of Pediatrics, University of California Irvine School of Medicine, Irvine, CA, USA.
  • Jankeel A; Center for Virus Research, University of California Irvine, School of Biological Sciences, Irvine, CA, USA.
  • Ibraim IC; Center for Virus Research, University of California Irvine, School of Biological Sciences, Irvine, CA, USA.
  • Ardo J; Center for Virus Research, University of California Irvine, School of Biological Sciences, Irvine, CA, USA.
  • Kasper K; Children's Hospital of Orange County, Orange, CA, USA.
  • Stephens D; Children's Hospital of Orange County, Orange, CA, USA.
  • Meyer A; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, USA.
  • Stehli A; Institute for Clinical and Translational Science, University of California Irvine, Irvine, CA, USA.
  • Condon C; Department of Pediatrics, Pediatric Exercise and Genomics Research Center, University of California Irvine, Irvine, CA, USA.
  • Londoño ME; Orange County Health Care Agency, Santa Ana, CA, USA.
  • Schreiber CM; University of California Irvine School of Medicine, Irvine, CA, USA.
  • Lopez NV; Children's Hospital of Orange County, Orange, CA, USA.
  • Camplain RL; University of California Irvine Health, Orange, CA, USA.
  • Weiss M; Department of Health Sciences, Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.
  • Golden C; Department of Health Sciences, Center for Health Equity Research, Northern Arizona University, Flagstaff, AZ, USA.
  • Radom-Aizik S; Children's Hospital of Orange County, Orange, CA, USA.
  • Boden-Albala B; Children's Hospital of Orange County, Orange, CA, USA.
  • Chau C; Department of Pediatrics, Pediatric Exercise and Genomics Research Center, University of California Irvine, Irvine, CA, USA.
  • Messaoudi I; Program in Public Health, University of California Irvine, Irvine, CA, USA.
  • Ulloa ER; Orange County Health Care Agency, Santa Ana, CA, USA.
Pediatr Res ; 90(5): 1073-1080, 2021 11.
Article in English | MEDLINE | ID: covidwho-1322460
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Understanding SARS-CoV-2 infection in children is necessary to reopen schools safely.

METHODS:

We measured SARS-CoV-2 infection in 320 learners [10.5 ± 2.1 (sd); 7-17 y.o.] at four diverse schools with either remote or on-site learning. Schools A and B served low-income Hispanic learners; school C served many special-needs learners, and all provided predominantly remote instruction. School D served middle- and upper-income learners, with predominantly on-site instruction. Testing occurred in the fall (2020), and 6-8 weeks later during the fall-winter surge (notable for a tenfold increase in COVID-19 cases). Immune responses and mitigation fidelity were also measured.

RESULTS:

We found SARS-CoV-2 infections in 17 learners only during the surge. School A (97% remote learners) had the highest infection (10/70, 14.3%, p < 0.01) and IgG positivity rates (13/66, 19.7%). School D (93% on-site learners) had the lowest infection and IgG positivity rates (1/63, 1.6%). Mitigation compliance [physical distancing (mean 87.4%) and face-covering (91.3%)] was remarkably high at all schools. Documented SARS-CoV-2-infected learners had neutralizing antibodies (94.7%), robust IFN-γ + T cell responses, and reduced monocytes.

CONCLUSIONS:

Schools can implement successful mitigation strategies across a wide range of student diversity. Despite asymptomatic to mild SARS-CoV-2 infection, children generate robust humoral and cellular immune responses. IMPACT Successful COVID-19 mitigation was implemented across a diverse range of schools. School-associated SARS-CoV-2 infections reflect regional rates rather than remote or on-site learning. Seropositive school-aged children with asymptomatic to mild SARS-CoV-2 infections generate robust humoral and cellular immunity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Students / Immunity, Humoral / SARS-CoV-2 / COVID-19 / Immunity, Cellular Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Pediatr Res Year: 2021 Document Type: Article Affiliation country: S41390-021-01660-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Students / Immunity, Humoral / SARS-CoV-2 / COVID-19 / Immunity, Cellular Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Pediatr Res Year: 2021 Document Type: Article Affiliation country: S41390-021-01660-x